These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 26628405)

  • 1. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
    Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
    Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five miRNAs Considered as Molecular Targets for Predicting Esophageal Cancer.
    Zhao JY; Wang F; Li Y; Zhang XB; Yang L; Wang W; Xu H; Liu DZ; Zhang LY
    Med Sci Monit; 2015 Oct; 21():3222-30. PubMed ID: 26498375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five miRNAs considered as molecular targets for predicting neuroglioma.
    Yang H; Wang Y
    Tumour Biol; 2016 Jan; 37(1):1051-9. PubMed ID: 26269115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
    Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
    Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis.
    Yang Y; Jia B; Zhao X; Wang Y; Ye W
    J Cell Biochem; 2019 Jun; 120(6):10463-10483. PubMed ID: 30582208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening the key microRNAs and transcription factors in prostate cancer based on microRNA functional synergistic relationships.
    Feng F; Wu J; Gao Z; Yu S; Cui Y
    Medicine (Baltimore); 2017 Jan; 96(1):e5679. PubMed ID: 28072703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-seq analysis of human vertebrae provides insight into the mechanism underlying GIOP.
    Ren H; Yu X; Shen G; Zhang Z; Shang Q; Zhao W; Huang J; Yu P; Zhan M; Lu Y; Liang Z; Tang J; Liang D; Yao Z; Yang Z; Jiang X
    Bone; 2019 Mar; 120():371-386. PubMed ID: 30503955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exploratory screening of potential pan-cancer biomarkers based on The Cancer Genome Atlas database].
    Zhou C; Ma X; Xing YK; Li LD; Chen J; Yao BY; Fu JL; Zhao P
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 53(3):602-607. PubMed ID: 34145869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of eight meta-signature miRNAs as potential biomarkers for oropharyngeal cancers.
    Li B; Kyung HM
    Cancer Genet; 2019 Apr; 233-234():75-83. PubMed ID: 30578154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and identification of epithelial-to-mesenchymal transition-related circRNA and miRNA in prostate cancer.
    Yan Z; Xiao Y; Chen Y; Luo G
    Pathol Res Pract; 2020 Feb; 216(2):152784. PubMed ID: 31882179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis.
    Wang W; Liu B; Duan X; Feng X; Wang T; Wang P; Ding M; Zhang Q; Feng F; Wu Y; Yao W; Wang Q; Yang Y
    Comb Chem High Throughput Screen; 2020; 23(2):148-156. PubMed ID: 31976830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
    Sharma P; Saraya A; Sharma R
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
    Zeng Y; Wang KX; Xu H; Hong Y
    J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.
    Gao L; Zhang LJ; Li SH; Wei LL; Luo B; He RQ; Xia S
    Pathol Res Pract; 2018 May; 214(5):732-749. PubMed ID: 29559248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of miRNAs in enterovirus 71-infected cells.
    Xun M; Ma CF; Du QL; Ji YH; Xu JR
    Virol J; 2015 Apr; 12():56. PubMed ID: 25889836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
    Liu H; Liu L; Zhu H
    J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.